1 / 56

Fact

Fact. The evidence base for most of what we do in intensive care is rather poor. Albumin - properties. Volume expansion 4% x 0.8, 5%, 20% x 3 Maintenance of colloid osmotic pressure (COP) Need a lot….no effect on other serum proteins..

Télécharger la présentation

Fact

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Fact The evidence base for most of what we do in intensive care is rather poor

  2. Albumin - properties • Volume expansion 4% x 0.8, 5%, 20% x 3 • Maintenance of colloid osmotic pressure (COP) • Need a lot….no effect on other serum proteins.. • Binding and transport - drugs (frusemide, antibiotics) toxins….. • Free radical scavenging • Immunological : stimulatory and inhibitory • Anticoagulatory effects and Procoagulatory effects : • inhibit plat aggregation, inhibition of factor Xa by ATIII, TEG shows early hypocoagulable effects Tobias et al, Jorgensen et al • Vascular permeability and over albuminisation Qiao et al • What are we prescribing 5%, 20%, 25% +/- crystalloid • Aluminum toxicity, hypotension (vasoactive peptides) • Myocardial depression (animal work ; Ca binding)

  3. Post transcriptional Proteins Advanced glycylation end product Wild mice Rage -/- mice

  4. HAS and HES increased No rolling and decreased adherence and aggregation Albumin decreased activation of No and platelets Albumin and HES decrease E Selectin release Alb and HES decrease to varying degrees decrease No : endothelial interactions

  5. Albumin : Sepsis and thiol repletionQuinlan et al, Clinical Science 1998 95, 459 200 ml 20% albumin or placebo

  6. Which fluid ……SOAP-study Role of balanced solutions - acidosis, consider Cl levels

  7. Albumin and frusemide in hypoalbuminaemia in ALI Martin G Crit Care Med 2002 ; 30:2175 • 37 ventilated acute lung injury • Total protein < 5 g/dl • 5 day protocol of 25 g of 25% HAS 8 hrly + frusemide or placebo • Frusemide titrated to weight loss > 1kg/day • Total protein 1.9 vs 0.7 g/dl Albumin 1.5 vs 0.3 g/dl • Increased COP 8.3 vs 2.9 mmHg at study end • Weight loss 10 vs 4.7 Kg • Increased Na, HCO3 and decreased K • No change in creatinine

  8. Improved oxygenation : improved Pa02/Fi02 ratio by 40% No difference in PEEP No changes in SOFA scores, shock free days or rates of re-intubation No difference in % requiring mechanical ventilation

  9. Acute kidney injury

  10. mortality

  11. Albumin and diuretics and ascites • 126 cirrhotics ascites • Diuretics vs Diuretics + Alb 12.5 g/day • Diuretics vs Diuretics + Alb 25g/week as outpatient. Follow up over 3 yrs • Hospital stay shorter in Alb grp 20±1 vs 24±2 days p<0.05 • Risk of developing ascites lower in Alb grp • 19%, 56%, 69% vs 30%, 74%, 79% (p<0.02) • Survival similar in both groups • Gentilini et al J Hepatol 30(4):639 1999

  12. Terlipressin and albumin vs albuminMartin-Llahi M Gastroenterology 2008:134 • 1-2 mg 4hrly • Albumin daily 1g/kg • N=23 each grp • Improved renal function 43 vs 8% • No difference in 2 mnth survival • CVS complications • 4 Alb vs 10 T + Alb

  13. RCT Terlipressin in Type I HRSSanyal A Gatroenterology 2008 :134:1360 1 mg 6 hrly vs placebo Albumin in both groups If no response (30% decrease in creat) at day 4 : to 2mg 6 hrly 14 days Rx : 56 in each grp Success defined as creatinine < 1.5 mg/dl for 48 hrs by Day 14 Rx success : 25 vs 12.5 % Baseline to day 14 decrease in creatinine 0.7 vs 0 mg/dl Similar survival between grps HRS reversal improved 180 day outcome

  14. Terlipressin + Albumin vs Albumin

  15. 10 trials only type I and II Drug ± alb vs no intervention Vasoconstrictors + Alb : Effect on mortality at 15 days but not at 30, 90 or 180 days RR 0.6 (0.37-0.97) Terlipressin + Albumin vs Albumin : decreased mortality in type I RR 0.83 (0.65-1.05)

  16. Multivariate – baseline creatinine

  17. Albumin and renal impairment in patients with cirrhosis and SBPSort P et al N Engl J Med 1999 5; 341 (6):403 • SBP frequently associated with renal failure • Associated with decreased effective blood volume and high mortality • 126 patients iv cefotaxime or iv cefotaxime plus albumin (1.5g/kg) at day 0 and day 3 (1.0 g/kg) • 94% and 98 % had resolution of infection • Renal failure in 21 (33%) cefgrpvs 6 (10%) in alb/cefgrp p=0.002 • Mortality 18 (29%) vs 6 (10%) • At 3 months the mortality was 41% vs 22% p=0.03

  18. HAS (4.5%) vs HES (6%,0.5) in paracetamol hepatotoxicity: prospective cohort studyBernal W Lancet 2001 • Albumin HES • Number 51 51 • Age 35 (20) 35 (22) • Apache II 14 (17) 15 (16) • INR 3.3 (2) 3.3 (2.6) • Creatinine 124 (132) 142 (167) • ARF o/a 14 (27%) 17 (33%)

  19. Albumin HES • Crystalloid (72 hrs) • ml 6237 (6086) 6670 (6078) • ml/kg 29 (42) 38 (52) • Colloid (72 hrs) • ml 2000 (2875) 3000 (2812) • ml/kg 96 (104) 112 (92) • No differences in creatinine at any time point • RRT (n) 24 (47%) 25 (49%) • Death / LT 19 (37%) 22 (44%) • ICU stay 3 (6) 2 (11) • No relationship between colloid used and ARF on multivariate analysis • No difference if established ARF patients are excluded from study

  20. Today’s evidence .. tomorrow’s chip paper?

  21. 20 patients with SBP : randomized within 12 hrs 1.5 g/kg at day 1 and 1.0 g/kg at day 3 20% albumin given over 6 hours 18 hrs HES 6% given over 18 hours Well matched Studied at resolution of SBP ( ascitic taps)

  22. terlipressin Hepatology 2011 placebo 3 mmHg MAP, Bilirubin

  23. plasmapheresis standard Rx 67% NNT 5 46%

  24. Recognize Fluids and CVS status Ventilatory issues Drain ascites Ileus : stop feeding Ng drainage , flatus tubes Open abdomen Incidence 8 - 50%

  25. Albumin : Sepsis and thiol repletionQuinlan et al, Clinical Science 1998 95, 459 • Ligand binder, extracellular metal ion-binding and radical-scavenging antioxidant. • Baseline bloods • 200 ml 20% albumin or placebo • Alb 12.6 , 22.3 , 19 mg/ml at 0, 5min and 4 hrs • Thiol levels rose 138, 192 , 192 uM at 0, 5min and 4 hrs • Thiol levels remain elevated for 8 hrs - (33% of rise lost at 4 hrs)

More Related